Renal dysfunction has been associated with poor outcomes of wound healing in the diabetic population. The purpose of this study was to create an excisional wound healing model in diabetic mice with renal dysfunction to investigate the combined effects of diabetes and nephropathy on cutaneous ulcers. Renal impairment was introduced in diabetic db/db mice through unilateral nephrectomy and electrocoagulation of the contralateral kidney. Renal function was subsequently monitored with assays of blood urea nitrogen and spot urinary protein/creatinine ratio. After 8 weeks, splinted, full-thickness excisional wounds were created on the dorsal skin and harvested on postoperative days 7 and 14 for further evaluation of wound healing. Renal injury promoted the increase of blood urea nitrogen 3 weeks after initial operation, which was maintained at double the control level throughout the study, concomitantly leading to a significant increase of spot urinary protein excretion. Diabetic mice with renal injury displayed notably impaired wound healing processes, concurrent with reductions in cellular proliferation and angiogenesis, as well as increases in M1 polarized macrophages, infiltrated neutrophils, oxidative stress, and cellular apoptosis. Furthermore, quantitative polymerase chain reaction (qPCR) results displayed corresponding changes of related genes (TNF-α, IL-1β, SOD2) in the wounds of renal injured db/db mice. Renal manipulation in this study accelerated the progress of renal impairment, which was demonstrated to aggravate impaired cutaneous wound healing in diabetic mice.
INTRODUCTION
With its dramatically increasing prevalence, 1 diabetes mellitus ranked as the seventh leading cause of death in the US in 2015.
2 Among the population with diabetes, the majority of morbidity and mortality is caused by microvascular and macrovascular complications. [3] [4] [5] Diabetic nephropathy (DN) and foot ulcers are two major complications that have been demonstrated to be closely associated in multiple clinical reports. [6] [7] [8] [9] [10] Of diabetic patients, those with renal failure were more likely to have a foot ulcer, [7] [8] [9] and the outcome of the diabetic foot ulcer was much worse in patients with decreased renal function compared to those with normal renal function. 10 Wound healing is a complex multicellular process involving cell migration, proliferation, angiogenesis, immune response, and extracellular matrix (ECM) accumulation and remodeling, which are delicately regulated and susceptible to interruption or improper repair under persisting aberrant conditions. 11 Diabetes has been largely demonstrated to impair wound healing processes by inhibiting angiogenesis, cellular migration, and proliferation through multiple mechanisms, including hypoxia, oxidative stress, advanced glycation end products modification, and abnormal activation of metalloproteases. 11 Kidneys play an important role in maintaining organismal homeostasis, including fluid and electrolyte balance as well as excretion of wastes, of which numerous components lead to dermatological manifestations such as xerosis, pruritus, microangiopathy, and calciphylaxis. 12, 13 Renal dysfunction disturbs wound healing processes, which may be characterized by reduced angiogenesis, decreased proliferation, and disturbance of host inflammatory response. [14] [15] [16] Functional incompetence of mesenchymal stem cells was demonstrated in mice with renal dysfunction as well as in dialysis patients, represented by decreased angiogenesis and proliferation and increased cellular senescence. 17, 18 The ultra-excretion of nutrition characteristic of renal failure has also been demonstrated to be a major contributor to the poor wound healing process, 19 as have the numerous retained uremic components that have previously been characterized by toxicity in vivo. 20 Urea-induced carbamylation of low-density lipoprotein promoted the production of reactive oxidative species and accelerated senescence in human endothelial progenitor cells, subsequently impairing the healing process. 21, 22 Given the complexity and varied interactions between diabetes, nephropathy, and wound healing, the clarification of pathogenesis in an appropriate animal model is essential for understanding the intricate interaction among these risk factors for wound healing in the hopes of developing effective therapeutic strategies. The studies of wound healing associated with DN have been performed merely to investigate a single aspect of either diabetes mellitus 23, 24 or nephropathy, [14] [15] [16] whereas a simultaneous study looking at the effects of both diabetes mellitus concurrent with nephropathy have been lacking. Based on our previous wound healing animal model evaluating chronic kidney diseased mice, 16 we herein created a wound healing model in diabetic mice with renal injury, and preliminarily investigated the mechanisms of impaired wound healing under a DN model.
MATERIALS AND METHODS
Animals db/db mice (BKS.Cg-m +/+ Lepr db , 000642) were purchased from Jackson Laboratories (Bar Harbor, ME). Male db/db mice at 8-10 weeks old age with blood glucose higher than 300 mg/dL were used in this study. All animals were acclimatized in the temperature-controlled animal facility with a 12-hour light/dark cycle for at least 1 week, and fed with the standard mouse pellet diet and water ad libitum. Body weight was recorded routinely, and blood glucose was examined using Accu-Chek blood glucose test strips (Roche Diabetes Care, Inc. Indianapolis, IN). The kidney injury and skin wounding surgeries were implemented under anesthesia with inhaled isoflurane. All of the mice received preoperative analgesia via a subcutaneous injection of metacam (5 mg/kg). The animals were randomly divided into sham surgery and DN groups consisting of n = 6-8 for each time point. DN mice were defined as db/db mice that received kidney injury induction surgery as described following, while the sham group mice underwent approximate surgical interventions (anesthesia, depilation, cutaneous and abdominal wall incision, exposure of kidney, and wound closure) except for cauterized kidney injury. All of the animal procedures in this study were approved by the IACUC (Institutional Animal Care and Use Committee) of Northwestern University.
DN murine model
The DN mouse model was performed as described previously with minor modifications by our research group. 16 Briefly, after depilation and sterilization, a 1.5-cm midline incision was created in the dorsal skin of the lumbar region and retracted to the right side. The right kidney was then surgically exposed through another small incision in the right flank with its cranial terminus just deep to the rib cage.
The renal hilum was briefly clamped while 3 /4 of the right renal cortex, excluding approximately 1-mm around the hilum, was electrically cauterized at 25 mV output with a Malis Bipolar Coagulator (Codman & Shurtleff, Inc, Randolph, MA). Immediately following cauterization, the left kidney was freed from the surrounding soft tissues in a similar fashion, and removed after the renal hilum was tied with a 5-0 Vicryl suture close to the kidney to maintain hemostasis. Incisions in peritoneum and body wall were closed with 6-0 Vicryl sutures, and the skin incision was then closed with 6-0 nylon sutures. The animals were closely monitored and recovered in a warm environment after completion of the surgery.
Splinted excisional wound model
Eight weeks following the initial kidney injury operation, mice underwent the splinted excisional wound procedure as previously described by Galiano et al. 25 with minimal modifications. The splinted excisional wound healing murine model minimized wound contraction, allowing wound closure to occur by granulation tissue deposition and epithelialization, which mimics human delayed wound healing processes. Briefly, after depilation and sterilization with iodine, paired 6-mm circular, full-thickness wounds including the panniculus carnosus layer were created with a sharp iris scissor on the dorsal skin. A 10-mm inner diameter donut-shaped silicone sheet was adhered to the skin around the wound using a tissue adhesive (Vetbond, 3 M, St. Paul, MN) to splint the wound open, and then sutured onto the skin using continuous 6-0 nylon sutures. The wounds and splints were covered with a sterile semiocclusive dressing (TegaDerm, 3 M, St. Paul, MN). Animals were caged separately throughout the entire course of the experiment for prevention of damage to the splints and dressing by other mice. The wounds were photographed on postoperative day (POD) 0, 7, and 14 with a digital camera. Wound area was measured with Image J (NCBI), and normalized to splint area which remained constant. Healing rate was calculated as a reduction in the percent area of the original wound size, represented as: (original wound area -postop wound area)/ original wound area × 100%.
Assay of blood urea and urinary protein/creatinine ratio
Urea level of vein blood was analyzed every 2 or 3 weeks using a Quantichrom Urea Assay (DIUR-500, Bioassay Systems, Hayward, CA), and the protein to creatinine ratio in spot urine samples was also measured after 8 weeks of renal injury manipulation using a Quantichrom Protein Creatinine Ratio Assay Kit (DPCR-100, Bioassay Systems, Hayward, CA) according to manufacturer's protocols.
Kidney histological analysis
At 9 or 10 weeks after the initial renal injury operation (on POD 7 or 14 days after cutaneous wounding), the kidneys were harvested. One-millimeter thickness kidney sliced samples were fixed with 10% formalin, subsequently dehydrated and embedded in paraffin. Five-μm-thick paraffin sections were prepared for histological analysis of kidney sclerosis using Periodic acid-Schiff (PAS) staining, which detects polysaccharides such as glycogen and extracellular glycoprotein in tissue. Briefly, the samples were oxidized by periodic acid and then reacted with the Schiff reagent to present a purple-magenta color, followed by hematoxylin nuclear counterstaining.
Cutaneous wounds analysis
The wounds were harvested on POD 7 and 14. The full thickness wounds were excised, including a 4-mm cuff of surrounding cutaneous tissue using a 10-mm biopsy puncher, and bisected in the wound center. Half of the wound was fixed for histological analysis in 10% buffered formalin and dehydrated in serial alcohol, then embedded in paraffin. The remaining half of the wound was used for mRNA and protein extraction.
Five-μm-thick paraffin sections were prepared for routine histological assessment with hematoxylin and eosin (H&E) staining, or for immunohistochemistry (IHC) analysis as described below. The H&E-stained samples were photographed with a Nikon digital microscope camera (Nikon Instruments Inc., Melville, NY), and the epithelial gap and neo-granulation tissue deposition were measured using NISElements BR 2.30 computer image analysis system (Nikon Instruments Inc., Melville, NY). As illustrated in Supporting Information Figure S3 , epithelial gap was quantified by measuring the distance between the epithelial edges on opposing sides of the wound bed, which was also verified by Keratin 14 immunostaining, and granulation tissue area on both sides of the wound was digitally outlined and quantified by pixel area. All the histological analyses were performed in a blind manner.
Immunofluorescence or IHC staining
After deparaffinization and rehydration, the samples underwent antigen retrieval in citric acid buffer (pH 6.0) using a food steamer. The blood vessels were stained with rabbit anti-CD31 (abcam, ab28364, 1:50; Cambridge, UK), followed by incubation with Alexa-Fluor 555-conjugated anti-rabbit antibody (Invitrogen), and the nuclei counterstained with DAPI (4 0 ,6-diamidino-2-phenylindole). The macrophages and their subtypes were triply stained with rat anti-F4/80 antibody (Bio-RAD MCA497GA, 1:100; Des Plaines, IL) for panmacrophages, rabbit anti-CCR7 (abcam, ab32527, 1:400; Cambridge, UK) for M1 type macrophages, and goat antiarginase 1 (Santa cruz, sc18351, 1:200; Dallas, TX) for M2 type macrophages, and then incubated with Alexa-Fluor 488, 350, or 555 conjugated anti-rat, rabbit, or goat antibodies (Invitrogen, Carlsbad, CA), respectively. The stained samples were imaged using fluorescent microscopy.
IHC was performed to detect Keratin 14, Ki 67, neutrophil marker, and nitrotyrosine using the Avidin-Biotin Complex method (Vector Laboratories, Burlingame, CA). Briefly, tissue sections were incubated with rabbit anti-Keratin 14 (Covance, RPB-155P, 1:50,000; Princeton, NJ), rabbit anti-Ki67 (abcam ab15580, 1:1000; Cambridge, UK), rat antineutrophils marker (polymorphonuclear leukocytes, PMN), (Santa cruz, sc-71674, 1:1000; Dallas, TX) or rabbit antinitrotyrosine (Thermofisher scientific, A21285, 1:200; Waltham, MA) antibodies, respectively. This was followed by incubation with biotin-conjugated anti-rabbit or anti-rat IgG, subsequently detected using VECTASTAIN ABC Reagent (Vector laboratories) and visualized for HRP activity in brown or dark brown with DAB. The samples were analyzed under the Nikon Eclipse 50i light microscope. Ki67 or neutrophil marker staining in the wound edge area was counted and averaged in four randomly chosen high-power microscopic fields (HPF) at 400× magnification.
Western blotting
Wound tissue was homogenized in RIPA lysis buffer (50 mM Tris-Cl pH 7.4, 150 mM NaCl, 1% Triton-X100, 1% sodium deoxycholate, 0.1% SDS) containing 1 mM PMSF and proteinase inhibitors cocktail, and 50 μg of protein per lane were separated on an 8% PAGE gel. After transferring onto a nitrocellulose membrane, the nitrotyrosine protein level was detected by incubating with rabbit anti-nitrotyrosine antibody (1:1000), and subsequently with HRP-conjugated secondary antibody. The signal was visualized with a chemiluminescence detection kit (GE healthcare life science, Pittsburgh, PA), and captured by Li-cor C-Digit Blot scanner (Li-Cor, Lincohn, NE). Detection of β-actin (Santa Cruz Biotechnology, Dallas, TX) served as a loading control.
Terminal deoxynucleotidyl transferase dUTP nick end labeling staining
Transferase dUTP nick end labeling (TUNEL) staining was designed to detect DNA fragmentation by labeling the ends of DNA breaks during apoptosis. As described by the company manual (DeadEnd fluorometric TUNEL system, Promega, Madison, WI), rehydrated tissue sections were digested with 20 μg/mL of proteinase K, subsequently incubated with TdT reaction mix containing fluorescein-12-dUTP and terminal deoxynucleotidyl transferase, and cell nuclei were counterstained with DAPI. Apoptotic cells stained in bright green were counted in a blind manner and averaged in three randomly chosen HPF at 200× magnification under fluorescent microscopy.
Quantification of TNF-α, IL-1β, and SOD2 mRNA expression
Total RNA was extracted from wound tissue using TRI reagent (Sigma-Aldrich, St. Louis, MO), and contaminating DNA was removed with Turbo DNA-free kit (Ambion, Austin, TX). The cDNA was synthesized from one microgram of total RNA by superscript III reverse transcriptase (Invitrogen, Carlsbad, CA) with 100 ng of random primers in 20 μL volume per reaction. The mRNA levels of TNF-α, IL-1β and SOD2 was quantified from synthesized cDNA in a sequence detection system (ABI prism 7,000; Applied Biosystems, Foster City, CA) using SYBR green and genespecific primers. GAPDH was used as an endogenous control. The sequence of primers are as follows:
Statistical analysis
Student's unpaired t test was applied in this study, with a p-value less than 0.05 considered to be statistically significant. All values were represented as mean AE standard error.
RESULT

Renal damage in DN mice
The surgical technique combining unilateral nephrectomy with contralateral renal thermal injury leads to a low mortality rate in normal mice as demonstrated in our previous experiments. 16 Compared to normal mice, the db/db mice that underwent a similar kidney injury operation in this study also had a low mortality rate (1/21 mice), although the diabetic animals were notably more hyperglycemic. Blood urea nitrogen (BUN) of DN mice increased from 54.8 AE 3.8 to 82.6 AE 5.0 mg/dL as early as 3 weeks after initial kidney injury, and almost doubled (97.9 AE 9.2 mg/dL, p < 0.01, n = 15) at 8 weeks postoperatively, while the diabetic sham mice maintained stable BUN levels from 53.4 AE 6.5 to 55.4 AE 6.3 mg/dL (p > 0.05, n = 16, Figure 1B ) throughout the duration of this study. Similar to our prior non-DN mouse model, severe renal injury with continuous BUN level above 150 mg/dL was found in 10% (2/20 mice) of the diabetic animals within 3 weeks after the kidney injury operation. Except for excessively renal injured animals, BUN level in 15% (3/20 mice) of the operated mice remained at a relatively low level, less than 60 mg/dL even 8 weeks after surgery. Urinary excretion of protein in the kidney-injured diabetic mice was much higher than that of sham surgical diabetic mice, as indicated by the assay of spot urinary protein/creatinine ratio (7.81 AE 3.09 DN vs 3.66 AE 2.52 mg/mg sham, n = 8, p < 0.05, Figure 1C ). Both excessive and minor renal injured mice were excluded from the analysis.
Based on our previous studies, the animals that underwent a kidney injury operation were observed to have notably retarded growth in the wild type background mice. 16 However, db/db mice herein gained body weight throughout the experimental protocol despite the elevated BUN levels. Both the sham and nephropathy db/db mice maintained high levels of blood glucose throughout the study (Supporting Information Figure S1 ).
Renal injury was also histologically analyzed at 9 or 10 weeks after renal injury-induction surgery (Figure 1D-G) . Compared to sham surgery animals, the DN group was observed to have damage in the outer layer of cortex, exhibiting atrophic glomeruli, destroyed tubules and adherent tissue which resulted from cautery thermal injury. Histological analysis was also performed on the deeper portions of kidney not affected by cauterization directly. Increased mesangial ECM deposition in glomeruli of diabetic sham mice as a result of nonenzymatic glycosylation of proteins due to the hyperglycemia was noted, while nodular glomerulosclerosis was observed in DN mice demonstrating more deposition of ECM in glomeruli. The tubulointerstitial ECM deposition also increased in DN mice, as PAS staining displayed thicker intertubular matrix compared to diabetic sham mice.
Renal dysfunction aggravated diabetic wound healing impairments
Wound healing was evaluated macroscopically by wound photography and microscopically by histological analysis. By measuring the wound area from the photos taken on POD 0, 7, and 14 in Figure 2A 
Impaired cutaneous wound healing was further verified by microscopic analysis of histological wound sections to measure epithelial gap and neo-granulation area in H&E-stained and keratin-14-stained sections ( Figure 2C-H , p < 0.05, n = 6-8) compared to diabetic sham mice. Our previous study demonstrated that renal failure delayed wound healing rate as indicated by decreased epithelial migration and less granulation tissue growth by POD 7 and by POD 14 in nondiabetic mice. 16 In comparison, renal injured diabetic mice exhibited aggravated impaired wound healing with much delayed epithelial gap closure as indicated in Supporting Information Figure S4 .
Renal dysfunction decreased cellular proliferation and angiogenesis in diabetic wounds DN mice exhibited notable wound healing retardation by POD 14. Therefore, cellular proliferation and angiogenesis within the entire sampling of wounds were evaluated on POD 14 by counting cells stained positively for Ki67 and CD31, respectively. A notable difference between Ki 67 staining at the wound edge of diabetic sham and nephropathy wounds is illustrated in representative images ( Figure 3A and B) . Compared to sham diabetic mice, the wounds of DN mice displayed remarkably fewer proliferative cells (19.3 AE 6.2 vs 34.6 AE 14.9/HPF, p < 0.05, n = 6-8) ( Figure 3C ). DN mice also demonstrated decreased numbers of endothelial cells relative to diabetic sham control mice within healing tissue, as assessed by staining for CD31 (14.8 AE 5.6 vs 25.6 AE 10.5/HPF, p < 0.05, n = 6-8, Figure 3D-F) , denoting a decrease in neovascularization within the healing tissue of diabetic mice. According to the study published by Michaels et al., 26 in which CD31 expression in db/db mice POD 14 wounds was reduced by half compared to wild type mouse wounds, and CD31 positivestained numbers (438.6/mm 2 ) in wild-type mice POD 14 wounds in a previous publication, 16 CD31 expression in renal injured db/db mice POD 14 wounds was extrapolated to be around 130/mm 2 , which is marginally less than that (169.2/mm 2 ) of renal injured wild-type mice POD 14 wounds. 16 
Renal dysfunction increased inflammation and oxidative stress in diabetic wounds
Inflammation is an essential phase in the wound healing process, and its proper homeostasis is critical for timely tissue repair. Inflammatory cells play versatile roles in wound healing, including host defense, regulation of cellular proliferation, and angiogenesis, as well as the removal of necrotic cell debris. DN mice herein exhibited an increased inflammatory state during the wound healing process, represented by an increased total macrophage count (30.9 AE 8.1 vs 21.2 AE 6.7/HPF, p < 0.05, n = 6-8, Figure 4A and C) and M1/M2 macrophage ratio (2.69 AE 0.49 vs 0.88 AE 0.29, p < 0.05, n = 6-8, Figure 4D ), as well as increased infiltrated neutrophils (PMN) (12.7 AE 5.3 vs 6.3 AE 2.9, n = 6-8, Figure 4B and E), as determined from their presence in splinted wounds of diabetic sham and nephropathy mice on POD 14. The increased macrophages in wounds of renal-injured diabetic mice were predominantly accounted for by the increase of M1 type macrophages (Supporting Information Figure S5A and B). As would be expected from our findings in the inflammatory cells analysis, DN mice showed increased mRNA levels of TNF-α and IL-1β within wounds on POD 14 (p < 0.05, n = 6-8, Figure 4F and G). Unexpectedly, compared to sham surgical diabetic mice, the renal-injured diabetic mice did not demonstrate a significant increase of inflammatory cells and cytokines in wounds on POD 7 (Figure 4 and Supporting Information Figure S5 ).
Oxidative stress is one of pivotal factors that influence the progress of impaired wound healing. Therefore, we investigated the presence of nitrotyrosine, a marker of oxidative stress, within the wound area and edge on POD 14. DN mice exhibited stronger nitrotyrosine staining compared to sham surgical diabetic mice ( Figure 5A and B), which was also confirmed by Western blotting analysis ( Figure 5C ). To compensate for the excess production of ROS, the transcript encoding the anti-oxidative stress enzyme SOD2 was discovered to be significantly increased in DN mice ( Figure 5D ). Likely due to oxidative stress and uremia, increased numbers of apoptotic cells were observed in DN wound tissue compared to sham diabetic wound tissue, as demonstrated by TUNEL-stained diabetic sham and nephropathy wound samples (5.7 AE 2.3 vs 10.7 AE 2.1 per HPF, p < 0.01, n = 6-8) (Figure 5E-G) . 
DISCUSSION
The strong association between renal impairment and delayed diabetic wound healing has been observed in numerous clinical studies. However, the underlying pathogenesis of retardation in wound healing associated with DN is not yet well-understood. We have previously established separate splinted excisional wound healing models in either murine chronic kidney disease 16 or type 2 diabetes mellitus 23, 25 animals. Based on the paucity of DN wound healing models, we created a new murine model by inducing nephropathy in diabetic db/db mice for better understanding of the underlying changes of cutaneous ulcers associated with DN. The renal manipulation with our established method noticeably accelerated renal dysfunction in db/db mice, and the healing of splinted wounds in DN mice was remarkably delayed compared to diabetic mice with normal renal function or renal injured nondiabetic mice 16 . DN is a chronic progressive kidney disease which occurs in patients with long-standing uncontrolled hyperglycemia. Several murine DN models have been developed in type 1 and type 2 diabetic animals, 27 with the latter more prevalent for interventional studies due to its much higher prevalence (representing more than 90% of diabetes cases). The db/db mouse, a type 2 diabetes animal model, has been utilized extensively and displays many features analogous to human DN. 28 It is also considered to be the most appropriate diabetic wound healing model for investigation of pathogenesis and therapeutic intervention, as these animals exhibit the most severe impairment in wound healing compared with other well-accepted diabetic mouse models. 26 However, as a vehicle for studies of pathogenesis of and interventions for wound healing in DN, especially with regard to diabetic renal failure, the db/db mouse is somewhat limited by the rate of disease progression and the severity of renal dysfunction. 29 Renal manipulation through unilateral nephrectomy was previously reported to be performed on db/db mice to accelerate nephrotic progression [30] [31] [32] and induce profound renal functional impairment at 5-6 months of age. The BUN levels were increased by approximately 20% in unilateral nephrectomy mice compared to the sham surgery mice. 31 The technique consisting of unilateral nephrectomy plus contralateral renal thermal injury in this study remarkably accelerated the progression of DN, in which BUN levels significantly increased at as early as 3 weeks after surgery, and were maintained at a higher level throughout the entire 9 weeks of study.
The 5/6 nephrectomy is widely used for renal failure models. However, db/db mice had a low tolerance for this renal manipulation, which resulted in an approximately 70-80% mortality rate due to local complications or acute renal failure in our practice. Bilateral electrocoagulation of the renal cortex in two separate surgical procedures was first introduced to produce a chronic renal failure animal model with an extremely low mortality rate by Gagnon et al. in 1983 . 33 This was recently modified by Seth et al., 16 who performed the renal manipulation combining unilateral nephrectomy and electrocoagulation of the contralateral kidney concurrently in a single surgery under isoflurane inhaled anesthesia. By utilizing this modified technique, the team successfully produced a chronic kidney disease (CKD) model in C57BL/6 mice with an almost null mortality rate and high rates of renal failure. Given these advantages, the db/db mice that underwent this modified renal manipulation in our study had both a comparably low mortality rate as well as severe renal impairment similar to that of the nondiabetic mice. These animals also demonstrated negligible local complications, which further verified the feasibility of this technique in the diabetic mouse model. However, a limitation of this model that should be recognized is the technical variability of electrocoagulation during the surgical procedure, which likely led to the difference in degree of uremia described previously. 16 Impaired wound healing represented by decreased epithelialization and neo-granulation tissue growth has been previously demonstrated in diabetic animal models 23, 26 through utilization of our established splinted excisional wound model which minimizes the effects of contraction on wound healing in rodent models. Consistent with the clinical observation that diabetic patients with renal failure having worsened outcomes of cutaneous ulcer healing than patients with normal renal function, we demonstrated in this study that renal dysfunction exacerbated the impaired wound healing process in diabetic mice. Decreased angiogenesis (denoted by CD31-positive cells in the wound bed) and cellular proliferation (denoted by Ki67-positive staining in the wound bed) in diabetic wounds 23, 26 was further aggravated in our renal-injured diabetic mouse model, which resulted from renal impairment as was demonstrated previously in our nondiabetic chronic kidney disease wound healing model. 16 In addition, as one of the most important processes in wound healing, the host inflammatory response in DN mice has been demonstrated to be aberrant, as demonstrated by an increased infiltration of pro-inflammatory M1 macrophages, 34 as well as increased mRNA levels of TNF-α and IL-1. The increased oxidative stress also reflects the effect of uremia on diabetic ulcers, promoting cutaneous cellular apoptosis as depicted with TUNEL staining. Interestingly, the transcript expression of the antioxidant enzyme SOD2 was demonstrated to be up-regulated, which may represent a feedback response by the host prior to decompensation. Therefore, the effects of the intricate interactions between diabetes and renal dysfunction on wound healing should be taken into consideration to understand pathogenesis and propose treatment of foot ulcers in diabetic patients with renal impairment. We demonstrated that renal dysfunction impaired the splint cutaneous wound healing by influencing cellular proliferation, angiogenesis, and inflammation in wounds, in which different responses to renal injury existed between nondiabetic and diabetic mice. Renal dysfunction influenced wound healing by a large margin as early as POD 7 in nondiabetic mice. Unexpectedly, as splinted wound healing was substantially slowed in both diabetic non-nephropathy and DN murine models, the impact of renal dysfunction on diabetic wounds in the early stage (prior to POD 7) was only mildly detectable, and the influenced magnitude was less weighted compared to nondiabetic mice, as indicated in Supporting Information Figure S4 . This suggests that, in early stages, diabetes plays the major role in impairment of wound healing in DN mice. Alternatively, it is possible that the small number of resident cells in wounds in this model was not adequate for detection of differences between diabetes and DN, at least for the techniques we utilized in this study. In addition, in contrast to the large decrease in CD31 expression in wounds of renal injured nondiabetic mice relative to sham control mice, 16 CD31 expression was decreased moderately in renal injured diabetic mice relative to sham control diabetic mice, and CD31 expression in renal injured db/db mouse wounds was unexpectedly marginally reduced compared to renal injured wild-type mouse wounds. 16 Concurrent decrease of VEGF in wounds of renal-injured nondiabetic mice was not observed in the wounds of diabetic mice (data not shown), suggesting that the reduction of VEGF expression by diabetes 35 was not additively influenced by renal dysfunction in this study. It appears that the mechanisms of reduced angiogenesis between renal injured diabetic mouse wounds and renal injured wild-type mouse wounds were not the same. The impaired angiogenesis in DN was probably resulted from the accumulation of asymmetric dimethylarginine, one of uremic toxins, which was demonstrated to inhibit eNOS activity. 36 Further investigations into the individual cell types and cellular responses involved in DN wounds are encouraged for future studies. Meanwhile, due to differences in data collection and design, comparisons of responses to renal dysfunction between diabetic mouse wounds and prior wild-type wounds were made in an indirect way, thereby limiting the comparisons that can be made between the two groups.
The complexity of chronic wound healing in diabetic patients with renal dysfunction, as well as the characterization of interplay between diabetes, uremia and wound healing have been initially investigated through this DN animal model study, which allows for further elucidation of molecular pathogenesis of delayed wound healing. Given the advantage of recreating accelerated renal dysfunction, this animal model provides a new tool for the study of therapeutic strategies to treat DN-associated wounds over a shorter time course.
SUPPORTING INFORMATION
Additional supporting information may be found online in the Supporting Information section at the end of the article. Neo-granulation tissue is stained pale pink with densified blue nuclear staining in H&E staining (outlined with black dash line), compared to the original dermal tissue in dark pink with less blue nuclear staining. Figure 4 . Comparison of cutaneous wound healing between non-diabetic chronic kidney diseases (CKD) with diabetic chronic kidney diseases. Percentage of epithelial gap relative to their original size in wild type sham control mice (WTSham), non-diabetic (wild type) CKD mice (WT-CKD), diabetic (db/db) sham control mice (db-sham), and diabetic nephropathy mice (db-CKD) on POD 7 (WT-Sham: 3.1 AE 1.9%, WT-CKD: 37.8 AE 7.0%, db-Sham: 80.2 AE 12.8% and db-CKD:82.2 AE 14.6%) and on POD 14 (WT-Sham: 0%, WT-CKD: 27.3 AE 9.2%, db-Sham: 54.5 AE 13.8% and db-CKD:71.5 AE 15.2%). Compared to either sham diabetic mice or non-diabetic CKD mice, diabetic nephropathy mice demonstrated a delayed wound healing rate. Figure 5 . Inflammatory cells in the wounds of sham and renal-injured diabetic mice. Wounds in diabetic nephropathy mice demonstrated a significant increase in M1 type macrophages on POD14 (*p < 0.05, n = 6-8). B. No significant difference of infiltrated M2 subtype macrophages were presented in the wounds between sham and renal-injured mice on POD14. C. No noticeable change in infiltrated neutrophils (PMNs) was presented in the wounds between sham and renal-injured mice on POD7.
